Stephen Collins

At the Quatrini Family Office, stewardship is more than just wealth preservation—it is the art of sustaining and growing a lasting legacy. Our approach combines institutional-level investment discipline with the nuanced understanding of private family wealth, ensuring that each decision aligns with long-term objectives, family values, and intergenerational prosperity. We do not operate as a traditional wealth manager. Instead, we function as a trusted partner and co-investor, providing exclusive opportunities and strategic governance that preserve wealth while unlocking new avenues for growth.

A Global VC firm, led by entrepreneurs turned investors, backing repeat successful founders accelerating the future of Applied AI

A next-generation venture capital firm investing in transformative technologies and digital assets through both equity and token structures. We partner with exceptional founders to build and scale the future of software, finance, and infrastructure. In select cases, we incubate projects and take an active role in growth, offering hands-on support and driving operational improvements where needed. Our team brings deep experience across venture capital, private equity, investment banking, corporate finance, operations, and engineering.

At the Quatrini Family Office, stewardship is more than just wealth preservation—it is the art of sustaining and growing a lasting legacy. Our approach combines institutional-level investment discipline with the nuanced understanding of private family wealth, ensuring that each decision aligns with long-term objectives, family values, and intergenerational prosperity. We do not operate as a traditional wealth manager. Instead, we function as a trusted partner and co-investor, providing exclusive opportunities and strategic governance that preserve wealth while unlocking new avenues for growth.

At Dyve Biosciences, we leverage our proprietary transdermal platform to deliver intuitive, targeted pH modulation to treat a range of immunologic and oncologic diseases. By directly targeting the acidic microenvironments that drive cancer cell growth and inflammation, we are taking decades of proven science from the petri dish to the patient. Learn more at dyvebio.com.

Capital Q Ventures was founded with a simple vision of serving our Venture Partners and the financial needs of our Investors while promoting collaboration in the communities we become members of. We strive to continually enrich the financial industry with the most creative and highest performing alternative investments. We believe that assisting Venture Partners, rewarding Investors, and helping our communities are not mutually exclusive pursuits. Over the past 20 years, our Executive Team has developed deep relationships with a vast network, where we have had the privilege to work. This group of trusted colleagues and friends provides us the greatest foundation for the most promising investment opportunities, along with valuable insight. The obvious evolution of this work is to create premier alternative Investment products, providing access to our excellent investment opportunities to investors who may be seeking above-market risk-adjusted returns, from an experienced management team. We put the full weight of our resources behind our Ventrue Partners companies’ because their success translates to our success and because we know it delivers the highest returns to our investors. From the very beginning, we are committed to the success of the companies in our Portfolio and want to deliver the resources that inspire them, their employees, families, and communities. And we’re in it for the long haul.

A Global VC firm, led by entrepreneurs turned investors, backing repeat successful founders accelerating the future of Applied AI